Article Details

AstraZeneca Enters Another Major Market With This Indication | The Motley Fool

Retrieved on: 2021-09-04 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Enters Another Major Market With This Indication | The Motley Fool. View article details on hiswai: https://www.fool.com/investing/2021/09/04/astrazeneca-snags-ckd-approval-japan/

Excerpt

AstraZeneca has gained access to millions of potential patients with chronic kidney disease (CKD) in Japan with its new indication for Forxiga.

Article found on: www.fool.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up